Aytu BioScience (PK) Stock Price - AYTUW

-0.05 (-16.67%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aytu BioScience Inc (PK) AYTUW OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.05 -16.67% 0.25 0.25 0.30 0.26 0.30 16:00:06
Bid Price Ask Price Spread Spread % News
0.15 0.30 0.15 50.0% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8 6,555 $ 0.2633 $ 1,726 18,418 0.034 - 1.25
Last Trade Time Type Quantity Stock Price Currency
13:10:03 10 $ 0.22 USD

Aytu BioScience (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 136.00k 544.01k - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.05k $ - 0.00% - -

more financials information »

Aytu BioScience (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AYTUW Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.390.390.220.26042965,316-0.14-35.9%
1 Month0.200.550.120.433483712,2070.0525.0%
3 Months0.1451.250.05770.340383523,2730.10572.41%
6 Months0.0531.250.0340.328202719,9680.197371.7%
1 Year0.0981.250.0340.321487318,0100.152155.1%
3 Years0.05011.250.020.229870614,7580.1999399.0%
5 Years0.,3690.17212.5%

Aytu BioScience (PK) Description

Aytu BioScience is a specialty life sciences company focused on commercializing novel products in the field of urology. Aytu is initially concentrating on hypogonadism (low testosterone), male infertility, and sexual wellness and vitality, and the company plans to expand into other urological indications for which there are significant medical needs. The company currently markets Natesto, the only FDA-approved nasally-administered testosterone, which is indicated for the treatment of hypogonadism. Outside the U.S., Aytu also markets the company's proprietary MiOXSYS system, a novel, point-of-care diagnostic system with the potential to become a standard of care as an aid in the diagnosis of male infertility. MiOXSYS is CE Marked and Health Canada approved and has been sold in over 20 countries around the world. Aytu also markets ProstaScint, an FDA-approved radioimaging agent indicated to detect prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. Aytu also acquired wholly-owned subsidiary Nuelle, Inc., a personal health and wellness company focused on women's sexual wellbeing and intimacy that markets Fiera, a personal care device for women that is scientifically proven to enhance physical arousal and sexual desire.

Your Recent History
Aytu BioSc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.